Press Releases

Piramal Enterprises Appoints Khushru Jijina to its Board as Executive Director, Financial Services

Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

Piramal Pharma Solutions Enters Into a Master Services Agreement with Plus Therapeutics, Inc.

Piramal Capital & Housing Finance Ltd. raises INR 4,050 Crores via issuance of Non-Convertible Debentures (NCDs)

Piramal Lacto Calamine® Announces Brand Association with Actress Kajal Aggarwal

Piramal Enterprises Ltd. to Cover Cost for COVID-19 Vaccination for All its Employees and Family Members

Piramal Pharma Limited’s Consumer Products Division Launches ‘i-feel®’

Piramal Appoints Saurabh Mittal as Chief Technology Officer (CTO) of its Retail Finance Business

Piramal Group Announces the Appointment of Kalpesh Kikani as CEO, Piramal Alternatives

Piramal Enterprises Limited Announces Consolidated Results for Q3 & 9M FY2021

Piramal Pharma Limited’s Consumer Products Division Ropes in Manoj Bajpayee for its Skin-Care Soap ‘Tetmosol’

Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-Drug Conjugate

Piramal Pharma Solutions Invests ~$32 Million to Expand its Riverview Michigan Facility for Additional Capacity in Potent and Non-Potent API Development and Manufacturing

Piramal Sarvajal and Center for Water and Sanitation Launch Composite Water Vulnerability Index Tool

Piramal Enterprises Appoints Anjali Bansal as Independent Director to its Board

Standard Chartered and Piramal Sarvajal more than double their Commitment to Provide Access to Safe Drinking Water; will Benefit 300,000 lives

Piramal School of Leadership in Partnership with Emory University Announces India’s 1st Cohort of Social Emotional Ethical Learning Certified Facilitators

Piramal Pharma and Navin Fluorine Mutually Agree on Piramal Increasing its Stake to 100% in Convergence Chemicals

Piramal Enterprises Limited Announces Consolidated Results for Q2 & H1 FY2021

Piramal Pharma Consumer Products Division’s Tri-Activ Disinfectant Spray For Multi-Surfaces is 99.9% Effective Against the Covid-19 Virus in 1 Minute

Kunal Bahl and Suhail Nathani Appointed Independent Directors of Piramal Enterprises

Piramal Pharma Announces Completion of 20% Strategic Growth Investment by Carlyle

Piramal Pharma Solutions to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs

Piramal Enterprises Limited Announces Consolidated Results for Q1 FY2021 ended June 30, 2020

Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish

Piramal Critical Care Announces Strategic Partnership with US-Based Pharmaceutical Outsourcing Facility – Medivant Healthcare

Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment

Partnerships to Advance Public Health and the Economy in the COVID-19 Era

Piramal Pharma Solutions Announces Acquisition of Solid Oral Dosage Drug Product Facility in Sellersville, Pennsylvania from G&W Laboratories Inc.

Piramal Enterprises Limited Announces Consolidated Results for Q4 & FY2020 ended March 31, 2020

Piramal Swasthya Attends Over 2.5 Lakh Calls on COVID-19 via 104 Health Information Helpline

Piramal Swasthya Supports Government of Assam’s Sarathi 104 helpline; Attends to More Than 1 Lakh calls in a Month

Piramal Sarvajal continues to operate its Water ATMs in partnership with Bhubaneshwar Municipal Corporation during the COVID-19 pandemic

Piramal Group Commits INR 25 Crores to COVID-19 Relief Effort

Piramal Enterprises’ FY2019 Annual Report Ranked 1st in India and 8th Globally by League of American Communications Professionals

Piramal Enterprises’ Consumer Products Division Ropes in Sourav Ganguly as the Brand Ambassador for ‘Polycrol’, its Antacid Brand

CDPQ and Piramal Partner to Deploy US$300 M for Private Credit Financing in India

Piramal Enterprises Limited Announces Consolidated Results for Q3 & 9M FY2020 ended December 31, 2019

Piramal Pharma Solutions Invests ~CAD$25 Million to Expand its Aurora, Canada Facility with a State-of-the-Art API Manufacturing Wing

Piramal Realty Makes a Foray into Value Housing Segment

Piramal Enterprises Limited Rights Issue Over-Subscribed ~1.14 Times

Piramal Divests its DRG Business for US$950 Million

Piramal Enterprises Announces the Appointment of Jairam Sridharan to Lead its Foray into Consumer Finance

Piramal Enterprises Raises INR 1,750 Crores from Caisse de dépôt et Placement du Québec (CDPQ) via Preferential Allotment

India Resurgence Fund Receives Investment Commitment From Canada Pension Plan Investment Board (CPPIB)

Piramal Realty acquires 2.2 million sft in Mahim

Piramal Swasthya and The Rockefeller Foundation Announce Partnership to Accelerate India’s Public Health Transformation

Piramal Group Partners With IIFL Wealth on an AIF to Provide Last-Mile Funding for Select Real Estate Projects

Government of Rajasthan Partners with Piramal School of Leadership to Create a Model of Excellence for School Education in Jhunjhunu

Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment

Oil India Ltd. and Piramal Swasthya partner to launch SPARSHA mobile medical vans for the under-served communities of Assam & Arunachal Pradesh

Piramal Foundation and Gates Foundation Partner to Setup a Tribal Health Collaborative for India

Piramal Enterprises Raises Capital of ~INR 5,400 Crores (~US$ 770mn)

Piramal Enterprises Limited Announces Consolidated Results for the Second Quarter & Half Year ended September 30, 2019

Piramal Swasthya Recognized with ‘Inclusive Health Access Award’ for its High Impact Healthcare Platform

Piramal Capital & Housing Finance Launches its Housing Finance Business in Jaipur, Rajasthan

Piramal Enterprises Limited Announces Consolidated Results for the Quarter ended June 30, 2019

Piramal Foundation Partners with District Administration and NITI Aayog to Improve Quality of Education in Aspirational District of Narmada, Gujarat

CRISIL Reaffirms Highest Rating to Piramal Capital and Housing Finance for Commercial Paper Programme worth Rs.10,500 Crores

Piramal Capital & Housing Finance Announces the Launch of its Housing Finance Business in Indore, Madhya Pradesh

Piramal Foundation for Education Leadership Signs MoU with Emory University to Implement the Social Emotional Ethical Learning Curriculum

Piramal Pharma Solutions Expands its High Potency API Capability at Riverview, MI Facility

Piramal Foundation Partners with Assam Government to Improve Quality of Education across 5 Aspirational Districts, Guwahati, Assam

Piramal Foundation Leverages Internet of Things (IoT) to Sustain Water Resources across India

Piramal Capital & Housing Finance Expands its Housing Finance Presence in Gujarat

Piramal Enterprises Limited Signs MoU with Canada Pension Plan Investment Board

Piramal Enterprises Limited Announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2019

Piramal Foundation for Education Leadership Supports Government of Jharkhand and NITI Aayog to Improve Education Indicators in Pakur and Sahibganj

Piramal Sarvajal Partners with Sankei Giken India Pvt. Ltd. to Provide Access to Safe Drinking Water in Suthani and Kharkhari

IndiaRF Announces US$144 Million Investment in Panacea Biotec Ltd.

Piramal Pharma Solutions Transforms Chilkepally Mandal Parishad Primary School through its Community Engagement Programme

Piramal Enterprises Limited’s FY2018 Annual Report Ranked 1st in India and 6th Globally, by League of American Communications Professionals

Piramal Announces the Launch of Cinacalcet by its partner, Slate Run Pharmaceuticals, in the U.S.

Piramal Critical Care announces the U.S. Launch of Mitigo

Supreme Court Exempts Saridon from the List of Banned FDCs

Piramal Foundation Partners with Government of Maharashtra to Improve Healthcare and Access to Safe Drinking Water Across the State

Piramal Capital and Housing Finance Launches its Home Loan Product – ‘Bridge’

Piramal & Ivanhoé Cambridge Residential Equity Fund Announces INR 500 Crores Equity Investment in Lodha Palava City

Piramal Enterprises Limited Announces Consolidated Results for the Q3 of FY2019 & Nine Months ended December 31, 2018

Piramal Sarvajal Provides Accessible Safe Drinking Water Solutions across Bhubaneswar

Piramal Capital and Housing Finance launches its home loan product ‘AdvantAGE’

IndiaRF Announces US$156 Million Investment in Archean Group’s Marine Chemicals Business

Mr. Ajay Piramal, Chairman, Piramal Group, Conferred with Honorary Doctor of Science (Honoris Causa) Degree by IIT-Indore

Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai

Piramal Capital & Housing Finance Limited Announces the Launch of its Housing Finance Business in Ahmedabad

Piramal Enterprises Limited Announces Consolidated Results for the Second Quarter & Half Year ended September 30, 2018

Piramal Enterprises categorically Refutes Baseless Rumours on Real Estate Lending Portfolio

Piramal Pharma Solutions Recognized as ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2018.

Piramal Capital & Housing Finance Launches New Brand Campaign: ‘Bada Socho’

Piramal Capital and Housing Finance Receives Global Recognition by Euromoney Real Estate Survey 2018

Piramal Capital & Housing Finance Announces its Foray into a Select Non-Metro with the Launch of its Housing Finance Business in Nashik

ICRA upgrades long term credit rating of Piramal Capital & Housing Finance Limited to AA+ (Stable)

Piramal Foundation Partners with Government of Jharkhand to Improve Student Learning Outcomes in Government Schools of 2 Aspirational Districts – Pakur and Sahibganj

Piramal Enterprises Limited Announces Consolidated Results for the First Quarter ended June 30, 2018

Mr. Ajay Piramal, Chairman, Piramal Group, Conferred with the Prestigious International Advertising Association’s (IAA) Business Leader of the Year Award, 2018

Piramal Capital & Housing Finance Commits ~INR 650 crore to SAMHI Group; Targets Hospitality Book Size of INR 10,000 crore in Next 3 Years

Piramal Enterprises Annual Report FY2017 Receives Global Recognition; 2nd Best from India & Featured Among Top 50 in Asia-Pacific Region at the League of American Communications Professional Awards

Piramal Capital & Housing Finance Limited Receives a Rating of ‘CARE AA+; Stable’ From CARE Ratings

Piramal Foundation for Education Leadership Transforms the Education Ecosystem through its ‘School Excellence Program’ in Surat

Piramal Sarvajal Partners with Ujjivan Financial Services to Facilitate Access to Safe Drinking Water in Lisana, Rewari, Haryana

SGS India Partners with Piramal Sarvajal to Facilitate Access to Clean Drinking Water in Rural Andhra Pradesh

Ujjivan Financial Services Limited Partners with Piramal Swasthya to Launch Mobile Primary Healthcare Programme in Karnataka

Piramal Capital & Housing Finance Strengthens its Presence in Chennai with ~INR 200 Crore Sanction to Appaswamy Group, Chennai

Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018

Piramal Finance & Piramal Housing Finance conferred with Two Prestigious Awards at CREDAI MCHI Golden Pillar Awards 2018

Piramal Housing Finance Announces its Launch in Pune

Ajay Piramal, Chairman, Piramal Group, Conferred with the Coveted CNBC Asia’s India Business Leader of the Year Award, 2018

Piramal Pharma Solutions wins in six categories at the ‘CMO Leadership Awards 2018’

Piramal Finance Launches its Housing Finance Offering in Bangalore; Has Crossed INR 20,000 crores of wholesale loans in South Market

Piramal Sarvajal Marks World Water Day, with the Launch of ‘Safe Drinking Water’ Awareness Drive

Ujjivan Financial Services Partners with Piramal Swasthya to Launch Mobile Primary Healthcare Programme in Maharashtra

NITI Aayog Partners with Piramal Foundation to ‘Transform Aspirational Districts’ Across India

Piramal Finance Launches its Housing Finance Offering in the Delhi-NCR Market

Shriram Transport Finance Company Partners with Piramal Swasthya to Announce the Launch of Mobile Primary Healthcare Programme in Pune, Maharashtra

Piramal Realty Announces the Appointment of Naaman Atallah as Chief Executive Officer

Piramal Finance targets affordable and mid-income housing sector

Piramal Swasthya Announces the Launch of Mobile Medical Units in 4 Districts of Andhra Pradesh

Piramal Swasthya launches ‘104’ Arogya Sahayavani Health Helpline in Bengaluru

Piramal Realty Presents the Annual Vaikunth Flower Show

Piramal Finance Limited Forays into the Hospitality Sector

Piramal Swasthya and The University of New South Wales Sign Memorandum of Understanding (MoU) to Develop Public Healthcare Solutions in India

Piramal Enterprises Acquires Digeplex and Associated Brands for its Consumer Products Business

ICRA upgrades Piramal Finance Rating from AA Stable to AA Positive

Piramal Imaging and ASAN Medical Center announce Research and Development Collaboration Agreement

Piramal Realty Inaugurates Aranya Pavillion, a World Class Experience Centre at Piramal Aranya, Byculla

Piramal Swasthya Announces the Launch of D.E.S.H. – a Community-Based Cancer Screening Program for Early Detection of Oral, Breast and Cervical Cancer in Assam

Piramal Pharma Solutions wins ‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2017

Piramal Swasthya Announces the Expansion of its Project “ASARA” in the Hard-to-Reach Tribal Areas of Vishakhapatnam, Andhra Pradesh

Piramal Realty Launches Tower 2 at Piramal Revanta, an INR 4800 crore project

Ajay Piramal, Chairman, Piramal Group & Shriram Group, receives CNBC Asia Business Leader Award 2017

Piramal Pharma Solutions wins at prestigious CPhI Pharma Awards

Piramal Enterprises Limited Announces QIP to Raise Rs. 4996.2 crores

Press Release-Piramal Finance Limited’s commits INR 550crore to Rustomje…

Piramal Finance Limited Introduces a Unique ‘Flexi Line of Credit’ for the Renewable Energy Sector

Piramal Finance Limited Commits INR 1100cr To Embassy Group Across Multiple Transactions

Piramal Finance Limited Expands Its Investment Focus to Include Auto Component Space; Commits INR 565 Crore Across Two Transactions

Tollywood superstar and Polycrol Brand Ambassador, Prosenjit Chatterjee celebrates Maha Ashtami with his fans

Piramal Enterprises Consumer Products Division Launches Garden Sciencz by Jungle Magic

Piramal Imaging to Present New Research in PET Imaging at CTAD Annual Meeting

Piramal Pharma Solutions Announces Large scale Expansion of API Manufacturing Facilities

Khushru Jijina recognized as ‘AsiaOne Global Indian of the Year 2016-2017’

Piramal Finance Limited’s commits INR 550crore to Rustomjee Urbania in Thane

Piramal Finance Limited Accelerates its Presence in the Auto Sector; Sanctions INR400 Crores to Hema Engineering

Piramal Realty Launches Mumbai’s Largest Non-IT Commercial Development: Agastya Corporate Park

Piramal Finance Limited’s commits ~INR400crore in emerging & mid-market space across eight deals via its Emerging Corporate Lending vertical

Piramal Enterprises Wins Gold at LACP Vision Awards

Piramal Finance Limited Sanctions INR 280 crores to Puranik Builders

Piramal Realty to Acquire Land Parcel for INR 153 Crores from Nirmal Lifestyles Limited

Piramal Finance Announces the Launch of Piramal Housing Finance

Piramal Finance Limited Receives ‘Best Overall Investment Manager for Real Estate in India’ by Euromoney Real Estate Awards 2017

Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board

Piramal Pharma Solutions names John Fowler as its Chief Operating Officer

Piramal Finance Limited Recognised Amongst Top 10 India’s Great Mid-size Workplaces by Great Place to Work Institute

Piramal Finance Limited introduces a unique ‘Flexi Line of Credit’ for the renewable energy sector – sanctions an additional INR700cr to ACME Solar Holdings Limited

Piramal Finance Limited commits INR 1100cr to Embassy Group across multiple transactions

Piramal’s Consumer Products Division launches new variants of heritage Brand Lacto Calamine

Rajesh Laddha, Chief Financial Officer – Piramal Enterprises Limited to move to Shriram Capital Limited as Managing Director & Chief Executive Officer

Piramal Enterprises Limited Announces Consolidated Results for Q4 FY2017 and FY2017

Piramal Finance Limited Expands Its Investment Focus To Include Auto Component Space; Commits INR 565 Crore Across Two Transactions

Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on Responsible Self-Care

Piramal Enterprises Introduces ‘Paan’ flavour for its Leading Antacid Brand ‘Polycrol’; Ropes in Indian Film Actor Prosenjit Chatterjee as its Brand Ambassador for Eastern India

Piramal Enterprises Introduces ‘Paan’ flavour for its Leading Antacid Brand ‘Polycrol’; Ropes in Bollywood Actor Manoj Bajpayee as its Brand Ambassador

Piramal Realty Marks Exclusive Pre-Launch of Piramal Revanta at ‘The Revanta Royal Festival’ in Mulund

Piramal Swasthya and National Health Mission (NHM), Govt. of Assam partnership: Citizen Health Consultations and Services for Vulnerable and Remote Communities Reach Nearly 2 crore Mark

Piramal Pharma Solutions names Stuart E. Needleman as Chief Commercial Officer

Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.

Piramal Pharma Solutions augments integrated capabilities by expanding sterile manufacturing capabilities in Lexington, KY

Piramal Enterprises Limited – Outcome of Board Meeting

Piramal Fund Management Sanctions Investments of around INR 2000 Crore within three months of launching of Flexi Lease Rental Discounting (LRD)

Piramal Enterprises Limited and Ivanhoé Cambridge Announce Partnership to Invest in Residential Development in India

Piramal Enterprises Limited announces its plan to Enter Housing Finance

Piramal Enterprises announces Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC

Piramal Realty’s Vaikunth Flower Show to Pay Homage to Mahatma Gandhi in Second Edition

Piramal Fund Management increases footprint in South India; crosses INR 10,000crore in consolidated investments

Piramal Fund Management launches an Innovative Flexi Lease Rental Discounting (LRD) for Commercial Assets; Targets INR10,000 Crores by FY’18

Piramal Fund Management receives ‘Best Overall Investment Manager -India’ award, second year in a row by Euromoney real estate awards

Neuraceq Automated Synthesizer Synthera (Neuraceq Synthera) Received Shonin Approval in Japan

Piramal Enterprises Limited Consolidated Results for the Q2 and H1 FY2017

Piramal Realty celebrates lifestyle living, cross-cultural collaboration with the Japanese Lantern Fiesta at The Aranya Festival

Piramal Enterprises Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen’s injectable anesthesia and pain management products

Piramal Enterprises receives ‘Silver Award’ for iCan at the APPIES APAC Awards

Piramal Imaging Announces Strategic Partnership with PET Pharm Biotech for Exclusive Commercialization of Neuraceq™ in Taiwan

In the largest debt transaction within the real estate funding space, Piramal Fund Management invests Rs 2,320 crore in Lodha Group’s Projects

Piramal Enterprises Limited and Bain Capital Credit to pursue distressed debt investing in India

Piramal Realty inks milestone partnership with L&T Construction; launches exclusive inventory of elite harbour facing suites

Piramal Enterprises enters into an agreement to acquire Ash Stevens Inc., a US based CDMO for High Potency APIs (HPAPIs)

Piramal Pharma Solutions expands capacity for sterile manufacturing in Lexington

Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016

Piramal Realty forays into commercial real estate with launch of Piramal Agastya Corporate Park

Piramal Realty launches Phase II of Piramal Vaikunth; opens sales for towers Vahin and Vrisa

Piramal Enterprises Limited Consolidated Results for the Q4 FY2016 and FY2016

Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business

Shri. N. Chandrababu Naidu, Hon. Chief Minister of Andhra Pradesh flags off Chandranna Sanchara Chikitsa project; launches 275 mobile medical units for the state

Piramal Enterprises Ltd and APG Asset Management to fuel Essel Infra’s Solar IPP venture; commits USD 132 million investment

Ajay Piramal, Chairman, Piramal Group receives the SEN Sustainability Award in Philanthropy Category

Piramal Realty celebrates the rich history of South Mumbai with the Aranya Festival

Piramal Realty launches its signature project Piramal Aranya at Byculla

Piramal Enterprises launches India’s first ever Benzocaine based throat spray* – Throatsil

Piramal Fund Management launches novel ‘Piramal Preferred Partner’ program; intends to pre-sanction funding limits for chosen Tier 1 developers to pursue acquisitions; targets funding commitments of I

Piramal Group participates in the Make in India Week

Piramal Udgam becomes one of India’s first rural BPO to become ISO-certified

Piramal critical care and cumberland pharmaceuticals Announce launch of caldolor and vaprisol co-promotion

Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel® to Smith & Nephew

First of its kind “Vaikunth Flower Show” in Thane; showcasing over 1 million flowers

Piramal Enterprises acquires five brands from Organon India Pvt. Ltd. (OIPL) and MSD BV for its Consumer Products Business

Mr. Piyush Goyal- Minister of Power, Coal, New & Renewable energy and Nobel Peace Laureate Kailash Satyarthi visit the Piramal School of Leadership (PSL) at Bagar, Jhunjhunu District, Rajasthan

Piramal Foundation partners with Government of Rajasthan towards social development in the state

Piramal Realty launches Vivaan, one of the most premium towers of Piramal Vaikunth, exclusively for Dubai

Piramal healthcare invests £2.0 mn in scotland

Piramal Enterprises acquires the Baby Care Brand – Little’s for the Consumer Products Business

Cumberland pharmaceuticals and piramal enterprises Announce co-promotion agreement

Piramal Enterprises Limited Consolidated Results for the Q2 FY2016 and H1 FY2016

Piramal Pharma Solutions receives ‘API Supplier of the Year’ award at Global Generics and Biosimilar Award 2015

Piramal Pharma Solutions, CEO Vivek Sharma receives ‘CEO of the Year’ award at CPhI Awards 2015

Piramal Foundation receives ‘Corporate Trailblazer’ award from Prime Minister Narendra Modi

Piramal targets becoming the global market leader in development & manufacturing of Antibody Drug Conjugates (ADCs)

Piramal Realty draws a strong customer response for its first project, Piramal Vaikunth in Balkum, Thane

Piramal encourages pharma to embrace green chemistry ahead of CPhI

Piramal Realty launches a new community for natural and holistic living at Balkum, Thane: Piramal Vaikunth

Piramal Fund Management to exit from Omkar 1973 (Worli); clocks absolute returns of ~146% from Indiareit Domestic Scheme IV

Piramal Realty secures $150 million (INR 900 crore) from Goldman Sachs

Piramal Healthcare launches Stop AllerG in the allergy segment

Piramal Sarvajal Installs Water ATMs at L&T Realty’s Crescent Bay Bhoiwada Site

Warburg Pincus to invest INR 1800cr in Piramal Realty

Piramal Imaging to Present Research on PET Imaging and Influence of Beta-Amyloid Plaques in the Brain at Annual Alzheimer’s Association International Conference

Piramal Imaging Presents New Data on Florbetaben in Detecting Beta-amyloid Plaques in Patients with Suspected Alzheimer’s Disease

Piramal Enterprises renames its ovulation test kit brand as “i-know”

Piramal Imaging SA and Ci-Co Healthcare Announce Commercial Approval of Neuraceq™ in Korea

Decision Resources Group Sets Course in Helping Leading Healthcare Companies Understand the Convergence of Healthcare Markets

Piramal Fund Management commits INR 575cr to Ozone Urbana; makes largest residential investment in Bangalore

Piramal Enterprises Consolidated Results for the Fourth Quarter and Full Year ended 31 March 2015

Piramal Fund Management enters Ahmedabad with INR225cr transaction with Ganesh Housing

Piramal Imaging is Proud to Support Major New Research Study Assessing the Value of PET Scans in Alzheimer’s Disease and Dementia Diagnosis

Piramal Enterprises Limited agrees to acquire majority equity stake in Health SuperHiway Private Limited

Piramal Enterprises announces sale of its Hyderabad based Clinical Research Division to Indoco Remedies

Piramal Fund Management sanctions INR 1,200Cr to Omkar Realtors for Omkar 1973 Worli

Piramal Foundation of Education Leadership (PFEL) aims to impact 400 schools at Jhunjhunu, Rajasthan under its newly launched District Leadership Development Program (DLDP) program

Piramal Fund Management expands offering to include construction finance; Approves transactions worth INR1100cr in the first instance

Piramal Enterprises Consolidated Results for the Third Quarter and Nine Months ended 31 December 2014

Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

Piramal Enterprises’ Pharma Solution division receives four CMO Leadership Awards 2015

Piramal Enterprises’ Consumer Product division ropes in Juhi Chawla as brand ambassador for their brand ‘Jungle Magic’

Phone Doctor 104 Arogyavani crosses 1 million customer calls in Karnataka

Piramal Swasthya partners with NACO to launch India’s First National AIDS helpline – 1097

Piramal Imaging Taps M2i to Manufacture and Distribute NeuraCeq , in Ireland

Piramal Fund Management’s ‘Indiareit Apartment Fund’ oversubscribed within three months of launch; secures an aggregate INR500cr of commitments; commits INR125cr across three transactions

Piramal Enterprises ropes in Sharman Joshi as brand ambassador for their latest OTC product offering -‘QuikKool’

Piramal Enterprises announces Q2 & H1FY2015 results

Dr APJ Abdul Kalam visits the Piramal School of Leadership’s (PSL) at Bagar, Jhunjhunu District, Rajasthan

Piramal Swasthya crosses 5 million beneficiary benchmark in Assam

Piramal supports J&K’s disaster relief operations

Piramal Enterprises enters into a Joint Venture with Navin Fluorine for specialty Fluorochemicals with applications in healthcare

Piramal Sarvajal successfully completes a year in Jaipur through their ‘Jaipur Schools Program’

First US Commercial Neuraceq , Scan for Beta-Amyloid Plaque Imaging Performed at WVU Healthcare

Piramal Enterprises announces Q1FY2015 results

First Site in Europe Begins to Offer Commercial Scans Using Piramal Imaging’s NeuraCeq , for Beta-Amyloid Plaque Imaging

APG and Piramal Enterprises Limited Announce Strategic Investment Alliance

Piramal Sarvajal partners with Department of Irrigation and Public Health (DI&PH) to launch the first water ATM in Shimla

Dr Shashikant Mishra inaugurates Piramal Sarvajal’s water purification set-up in Rakhigarhi

Piramal Fund Management launches ‘Indiareit Apartment Fund’ ‘ a novel first-to-market fund strategy centered around institutional buying of residential units; collects INR100cr commitments in 10 day

Memorandum of Understanding between SBI Capital Markets Limited (SBICAP) and Piramal Enterprises Limited (PEL)

Piramal’s NCE Research shared Preclinical efficacy data for Two Promising Molecules at the American Diabetes Association’s 74th Scientific Sessions

Research on Piramal Imaging’s NeuraceqTM (florbetaben F18 injection) takes Center Stage at SNMMI

Piramal imaging research key topic at society of nuclear medicine and molecular imaging annual meeting

Piramal Enterprises Limited ( “PIRAMAL “) Acquires 9.99% Equity Stake In Shriram City Union Finance Limited ( “SHRIRAM City Union “)

Piramal Capital combines its private equity business (Indiareit) and lending arm (Piramal Finance) to form an integrated vertical ‘ Piramal Fund Management

Piramal Sarvajal has been acknowledged as global pioneer in remote tracking decentralized water solution

AC Immune and Piramal Imaging announce out-licensing agreement for the development of Tau protein diagnostics in Alzheimer’s disease

Piramal Enterprises announces Q4FY2014 and full year FY2014 results; the Board of Directors recommends dividend of Rs. 52.5 per equity share with a total outlay of Rs. 1,059.93 Crores for FY2014

NeuraceqTM (florbetaben F18 injection) Data: an Emerging Science Topic at the American Academy of Neurology Annual Meeting in Philadelphia

Piramal enterprises limited ( “piramal”) agrees to acquire 20% equity stake in shriram capital limited ( “shriram capital”)

Piramal Enterprises Limited ( “Piramal “) Agrees To Sell Equity Stake In Vodafone India Limited

Piramal Enterprises and Merisant sign an exclusive sales & distribution partnership for Equal ? in India

Piramal Enterprises’ Pharma Solution Division receives two coveted CMO Leadership Awards (2013) for “Quality ” and “Reliability “

Piramal Enterprises receives GLP Compliance Certificate from NGCMA for its Research & Development facility located in Mumbai, India

Piramal Foundation joins the $14 million Dasra-Kiawah Trust-USAID Alliance

Shri Hemant Soren, Hon’ble Chief Minister & Piramal Swasthya inaugurate ‘104 Health Information Helpline’ in Jharkhand

Piramal Imaging Announces EU Approval of NeuraCeqTM (florbetaben 18F)* for PET Imaging of Beta-Amyloid Neuritic Plaque Density in the Brain

CPPIB and Piramal Enterprises Limited announce a US$500m Strategic Alliance for Residential Development Debt Financing in India; Appoint Indiareit as Advisor

Piramal Enterprises announces Q3FY2014 results

Indiareit announces final close of Domestic Scheme V at INR1000 crores; returns INR100 crores+ oversubscription; Commits 25% of corpus across three transactions

Decision Resources Group acquires Relay Technology Management

CHMP Recommends EU Approval of Piramal Imaging’s NeuraCeqTM (Florbetaben 18F)* for PET Imaging of Neuritic Beta-Amyloid Plaques in the Brain

Piramal Foundation promotes “Education Leadership ” through the Piramal School of Leadership (PSL) at Bagar, Jhunjhunu District, Rajasthan

Piramal Imaging Enters into a Strategic Partnership and Exclusive Licensing Agreement with Ci-Co Healthcare for Commercialization of Florbetaben F18

Indiareit receives an overwhelming response; raises INR 800cr for Domestic Fund V

Piramal Enterprises acquires the brand CALADRYL ? in India

Piramal Enterprises announces Q2FY2014 Results

Piramal Imaging Highlights New Data for Beta-Amyloid Imaging Agent Florbetaben F18 at EANM 2013

Piramal Enterprise’ heritage brand ‘Saridon’ wins three prestigious Emvie Media Awards

Five Star Safety Ratings awarded to Piramal Enterprises Ltd. by British Safety Council

Dr. Raman Singh, Chief Minister of Chhattisgarh & HMRI (Piramal Foundation) inaugurates 104 Heath Information Helpline in Raipur

Piramal | Healthcare to invest $ 11 million in hormonal healthcare production at its Morpeth, UK, facility

Honorable Minister of Health & Family Welfare, GoI inaugurates HMRI’s Innovative Call Centre for Pregnant Women and Children in Assam

Piramal Imaging provides comments in response to the centers for Medicare and Medicaid Services’ (Cms’) proposed coverage decision for Beta-Amyloid Positron Emission Tomography (Pet)

Piramal Water Ltd inaugurates the ‘Jaipur Schools Program’

Indiareit announces interim close of Domestic Scheme V at INR 300 crore; Also reaches final close of Mumbai Redevelopment fund with targeted corpus of INR 500 crore

Piramal Enterprises Limited receives IND approval for P7435, its novel DGAT1 inhibitor for treatment of Lipid Disorders and Diabetes

Piramal Enterprises announces Q1FY2014 Results

The centers for medicare & medicaid services (cms) draft decision could limit patient access to new technology that may help in diagnosing dementia

Piramal’s healthcare vertical invests USD $2.5 million to further expand commercial ADC capacity

Piramal Water Pvt. Ltd honoured with ‘Enabling Technology Award of the Year 2013’

Piramal Enterprises Diagnostic Division launches 3 New Instant Diagnostic Devices in QDx range

Piramal Imaging Highlights New Data for Florbetaben and Other Investigational Radiopharmaceuticals at SNMMI 2013

Piramal Enterprises Limited receives IND approval from the US FDA for its GPR40 agonist P11187; an anti-diabetic molecule

Piramal Imaging Welcomes Ana M. Catafau, M.D., Ph.D., as VP, Clinical Research and Development, Neurosciences

Piramal Enterprises announces Q4 FY2013 result

Piramal Enterprises Limited acquires ~10% equity stake in Shriram Transport Finance Company Limited

Piramal Enterprises’ expands its Jungle Magic portfolio with the launch of Banditz

Piramal Enterprise celebrates the enduring beauty of “Audrey Hepburn ” with the launch of, “Lacto Calamine RENEU “, an all new anti-ageing cream

Indiareit announces investments totaling INR 200 crore across two domestic funds

Piramal Enterprises Limited (PEL) and Tata Memorial Centre (TMC) forge alliance to advance understanding of cancer biology and develop tools for personalized medicine

Piramal Imaging announces the acceptance for review of [18F] florbetaben by the FDA and EMA for the visual detection of beta-amyloid in Alzheimer’s disease

Piramal Enterprises announces Q3 FY2013 result

Indiareit announces exits worth INR 440 crore from three earlier funds and a third party mandate

Piramal Healthcare announces settlement of patent litigation with Baxter Halthcare related to generic version of SUPRANE (Desflurane)

Piramal Healthcare to acquire 5.5% stake in Vodafone

Piramal Healthcare Limited to acquire the Anesthetic products business of Bharat Serums And Vaccines Limited

Revenues for FY2009 up by 14.4% to Rs. 32.8 billion

Piramal Healthcare Limited Acquires U.S. Inhalation Anesthetic Gas Distribution Business of RxElite, Inc.

Piramal Healthcare Limited Completes Acquisition of Minrad International, Inc.

Piramal Diagnostics introduces Asia’s first high-definition

Nicholas Piramal and Pierre Fabre Laboratories sign agreement on research in oncology in the presence of French President Nicolas Sarkozy

Nicholas Piramal Announces Drug Discovery and Development Agreement with Merck & Co., Inc.

Nicholas Piramal India Limited’s IND-P276- a new drug discovery from Mumbai, India has been approved by USFDA